Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avalon Pharmaceuticals (AVRX) -- Ignore unavailable to you. Want to Upgrade?

To: Rutgers who wrote (2)	10/7/2005 12:08:20 PM
From: Rutgers	Read Replies (1) \| Respond to of 9

Key Stats: Avalon Pharmaceuticals, Inc. 20358 Seneca Meadows Parkway Germantown, MD 20876 Phone: 301-556-9900 Fax: 301-556-9910 Web Site: avalonrx.com Of the 2.75 million from the dutch auction IPO, it appears that Insiders purchased almost 1 million of those. WALTON ALAN G Director 10% owner 181,400 $10.5 $1,904,700.00 673,261 Whitaker Raymond J Director 203,900 $10.5 $2,140,950.00 203,900 ROYSTON IVOR Director 136,000 $10.5 $1,428,000.00 136,000 ADVIESBEHEER GIMV LIFE SCIENCES NV 10% owner 181,400 $10.5 $1,904,700.00 181,400 Beneden Patrick Van Director 10% owner 181,400 $10.5 $1,904,700.00 181,400 From The Deal.com As of the offering, the Germantown, Md.-based company has a market capitalization of approximately $92.3 million. The biopharmaceuticals company's $80 million in venture financing came primarily through a $70 million second round in December 2001. Toronto's CDP Sofinov led that round with an $8 million investment. U.K.-based EuclidSR Partners; France's AIG Global Investment Group; Hambrecht & Quist Capital Management LLC of San Francisco; MDS Capital Corp. and RBC Capital Partners, both of Toronto; Montreal's GeneChem Mnagement Inc.; and OrbiMed Advisors LLC and KBL Healthcare Ventures, both of New York, also came in as new investors. Previous investors Oxford Bioscience Partners, GIMV NV, Forward Ventures, Emerging Technology Partners LLC and Maryland Department of Business and Economic Development also came back to build on a $10 million first round from June 2000. AVALON's largest shareholder is GIMV, which owns 12.2% of the company.